Daily Stock Analysis, KURA, Kura Oncology Inc, priceseries

Kura Oncology Inc. Daily Stock Analysis
Stock Information
Open
20.38
Close
20.35
High
20.44
Low
20.14
Previous Close
20.20
Daily Price Gain
0.15
YTD High
40.01
YTD High Date
Jan 7, 2021
YTD Low
15.12
YTD Low Date
Aug 20, 2021
YTD Price Change
-13.66
YTD Gain
-40.16%
52 Week High
43.00
52 Week High Date
Dec 9, 2020
52 Week Low
15.12
52 Week Low Date
Aug 20, 2021
52 Week Price Change
-8.45
52 Week Gain
-29.34%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 9. 2016
5.45
Dec 30. 2016
5.91
14 Trading Days
8.48%
Link
LONG
Feb 27. 2017
7.60
Mar 6. 2017
8.20
5 Trading Days
7.89%
Link
LONG
Apr 6. 2017
9.20
Apr 28. 2017
10.19
15 Trading Days
10.80%
Link
LONG
Aug 3. 2017
9.50
Aug 8. 2017
10.32
3 Trading Days
8.68%
Link
LONG
Sep 8. 2017
11.80
Sep 11. 2017
12.62
1 Trading Days
6.99%
Link
LONG
Dec 20. 2017
14.30
Jan 4. 2018
15.29
9 Trading Days
6.96%
Link
LONG
Jan 11. 2018
15.65
Feb 5. 2018
18.72
16 Trading Days
19.60%
Link
LONG
Feb 15. 2018
21.05
Mar 8. 2018
22.47
14 Trading Days
6.75%
Link
LONG
Jun 29. 2018
18.20
Jul 23. 2018
20.03
15 Trading Days
10.04%
Link
LONG
Nov 28. 2018
12.32
Dec 17. 2018
13.15
12 Trading Days
6.73%
Link
LONG
Jan 4. 2019
15.15
Jan 17. 2019
16.02
9 Trading Days
5.73%
Link
LONG
Apr 8. 2020
8.99
May 13. 2020
14.50
24 Trading Days
61.30%
Link
LONG
May 15. 2020
15.30
Jun 3. 2020
16.63
12 Trading Days
8.72%
Link
LONG
Aug 4. 2020
17.16
Sep 4. 2020
23.15
23 Trading Days
34.93%
Link
LONG
Sep 8. 2020
25.59
Sep 23. 2020
28.45
11 Trading Days
11.16%
Link
LONG
Sep 24. 2020
28.80
Oct 20. 2020
32.41
18 Trading Days
12.53%
Link
LONG
Nov 5. 2020
34.92
Nov 18. 2020
37.27
9 Trading Days
6.74%
Link
LONG
Dec 4. 2020
36.80
Dec 7. 2020
39.81
1 Trading Days
8.18%
Link
LONG
Dec 8. 2020
38.86
Dec 9. 2020
40.93
1 Trading Days
5.33%
Link
Company Information
Stock Symbol
KURA
Exchange
NasdaqGS
Company URL
http://www.kuraoncology.com
Company Phone
(858) 500-8800
CEO
Troy E. Wilson
Headquarters
California
Business Address
3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001422143
About

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Description

Developing in-licensed protein inhibitors for solid tumors and blood cancers.